Morgan M. Philbin, Ph.D.
Affiliations: | 2013 | Health, Behavior, and Society | Johns Hopkins University, Baltimore, MD |
Area:
Public Health, Health Care ManagementGoogle:
"Morgan Philbin"Cross-listing: Anthropology Tree
Parents
Sign in to add mentor| Lori Leonard | grad student | 2013 | Johns Hopkins (Anthropology Tree) | |
| (The promise of an AIDS-free generation: An inquiry into the experiences of healthcare providers and HIV-positive adolescents.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dube K, Perez-Brumer A, Patel H, et al. (2024) "This is actually a really unique moment in time": Navigating Long-Acting HIV Treatment and HIV Cure Research with Analytical Treatment Interruptions - A Qualitative Interview Study in the United States. Aids Research and Human Retroviruses |
| McCrimmon T, Collins LF, Perez-Brumer A, et al. (2024) Long-Acting Injectable Antiretrovirals for HIV Treatment: A Multi-Site Qualitative Study of Clinic-Level Barriers to Implementation in the United States. Aids Patient Care and Stds. 38: 61-69 |
| Dubé K, Barr E, Philbin M, et al. (2023) Increasing the meaningful involvement of women in HIV cure-related research: a qualitative interview study in the United States. Hiv Research & Clinical Practice. 24: 2246717 |
| West BS, Diaz JE, Philbin MM, et al. (2023) Past-year medical and non-medical opioid use by HIV status in a nationally representative US sample: Implications for HIV and substance use service integration. Journal of Substance Use and Addiction Treatment. 147: 208976 |
| Philbin MM, McCrimmon T, Shaffer VA, et al. (2022) A Patient Decision Aid (i.ARTs) to Facilitate Women's Choice Between Oral and Long-Acting Injectable Antiretroviral Treatment for HIV: Protocols for its Development and Randomized Controlled Pilot Trial. Jmir Research Protocols. 11: e35646 |
| Bazzi AR, Valasek CJ, Streuli SA, et al. (2022) Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred Over Other Modalities Among People Who Inject Drugs: Findings from a Qualitative Study in California. Aids Patient Care and Stds. 36: 254-262 |
| Dahlby L, Boyd J, Knight R, et al. (2022) The perspectives of street-involved youth who use drugs regarding the acceptability and feasibility of HIV pre-exposure prophylaxis: a qualitative study. Aids Care. 1-8 |
| Philbin MM, Perez-Brumer A. (2022) Promise, perils and cautious optimism: the next frontier in long-acting modalities for the treatment and prevention of HIV. Current Opinion in Hiv and Aids. 17: 72-88 |
| Philbin MM, Menza TW, Legrand SH, et al. (2021) Structural-Level Racial-, Sexual Orientation-, and HIV-Related Discrimination and Subsequent Criminal Justice Involvement Among Young, Black, Men Who Have Sex With Men in North Carolina. Stigma and Health. 8: 170-178 |
| Philbin MM, Bergen S, Parish C, et al. (2021) Long-Acting Injectable ART and PrEP Among Women in Six Cities Across the United States: A Qualitative Analysis of Who Would Benefit the Most. Aids and Behavior |